Studies on the gastric secretion inhibitory substance in human saliva (Salivogastrone). II. Clinical study.
D000328:Adult; D004381:Duodenal Ulcer / Q000188:drug therapy; D005260:Female; D005750:Gastric Juice / Q000378:metabolism*; D005756:Gastritis / Q000188:drug therapy; D005768:Gastrointestinal Hormones / Q000627:therapeutic use; D005773:Gastroscopy; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos / Q000008:administration & dosage; D011859:Radiography; D012463:Saliva / Q000032:analysis*; D013270:Stomach / Q000000981:diagnostic imaging; D013276:Stomach Ulcer / Q000188:drug therapy
D005768:Gastrointestinal Hormones; D006025:Glycosaminoglycans; D010919:Placebos